Håvard T Garberg1,2, Marianne U Huun1,2, Javier Escobar1,3, Jose Martinez-Orgado4, Else-Marit Løberg5, Rønnaug Solberg1, Ola Didrik Saugstad1,2. 1. Department of Pediatric Research, Women and Children's Division and Institute for Surgical research, Oslo University Hospital, Rikshospitalet, Oslo, Norway. 2. University of Oslo, Oslo, Norway. 3. Neonatal Research Unit, Health Research Institute Hospital La Fe, Valencia, Spain. 4. Division of Neonatology. Hospital Clinico San carlos-IdISSC, Madrid, Spain. 5. Department of Pathology, Oslo University Hospital, Ullevål, Oslo, Norway.
Abstract
BACKGROUND: Cannabidiol (CBD), a nonpsychoactive cannabinoid, has shown neuroprotective actions after neonatal hypoxia-ischemia (HI) in animals. We wanted to further explore the effects of CBD, alone and in conjunction with hypothermia, in a piglet model of global HI. METHODS: Fifty-five anesthetized newborn piglets were randomized to either controls (n = 7) or HI (n = 48) by ventilation with 8% O2 until mean arterial blood pressure reached 20 mmHg and/or base excess reached -20 mmol/l. After resuscitation piglets were randomized to either: vehicle (VEH), CBD 1mg/kg, VEH+hypothermia (H) or CBD 1mg/kg+H (each n = 12). Piglets were euthanized 9.5 h after HI and plasma, urine, cerebrospinal fluid, and brain tissue were sampled for analysis. RESULTS: HI induced global damage with significantly increased neuropathology score, S100B in cerebrospinal fluid, hippocampal proton magnetic resonance spectroscopy biomarkers, plasma troponin-T, and urinary neutrophil gelatinase-associated lipocalin. CBD alone did not have any significant effects on these parameters while CBD+H reduced urinary neutrophil gelatinase-associated lipocalin compared with VEH+H (P < 0.05). Both hypothermic groups had significantly lower glutamate/N-acetylaspartate ratios (P < 0.01) and plasma troponin-T (P<0.05) levels compared with normothermic groups. CONCLUSION: In contrast to previous studies, we do not find significant protective effects of CBD after HI in piglets. Evaluation of CBD in higher doses might be warranted.
BACKGROUND:Cannabidiol (CBD), a nonpsychoactive cannabinoid, has shown neuroprotective actions after neonatal hypoxia-ischemia (HI) in animals. We wanted to further explore the effects of CBD, alone and in conjunction with hypothermia, in a piglet model of global HI. METHODS: Fifty-five anesthetized newborn piglets were randomized to either controls (n = 7) or HI (n = 48) by ventilation with 8% O2 until mean arterial blood pressure reached 20 mmHg and/or base excess reached -20 mmol/l. After resuscitation piglets were randomized to either: vehicle (VEH), CBD 1mg/kg, VEH+hypothermia (H) or CBD 1mg/kg+H (each n = 12). Piglets were euthanized 9.5 h after HI and plasma, urine, cerebrospinal fluid, and brain tissue were sampled for analysis. RESULTS:HI induced global damage with significantly increased neuropathology score, S100B in cerebrospinal fluid, hippocampal proton magnetic resonance spectroscopy biomarkers, plasma troponin-T, and urinary neutrophil gelatinase-associated lipocalin. CBD alone did not have any significant effects on these parameters while CBD+H reduced urinary neutrophil gelatinase-associated lipocalin compared with VEH+H (P < 0.05). Both hypothermic groups had significantly lower glutamate/N-acetylaspartate ratios (P < 0.01) and plasma troponin-T (P<0.05) levels compared with normothermic groups. CONCLUSION: In contrast to previous studies, we do not find significant protective effects of CBD after HI in piglets. Evaluation of CBD in higher doses might be warranted.
Authors: Hector Lafuente; Francisco J Alvarez; M Ruth Pazos; Antonia Alvarez; M Carmen Rey-Santano; Victoria Mielgo; Xabier Murgia-Esteve; Enrique Hilario; José Martinez-Orgado Journal: Pediatr Res Date: 2011-09 Impact factor: 3.756
Authors: Francisco J Alvarez; Hector Lafuente; M Carmen Rey-Santano; Victoria E Mielgo; Elena Gastiasoro; Miguel Rueda; Roger G Pertwee; Ana I Castillo; Julián Romero; José Martínez-Orgado Journal: Pediatr Res Date: 2008-12 Impact factor: 3.756
Authors: Pierre Gressens; John Dingley; Frank Plaisant; Helen Porter; Leslie Schwendimann; Catherine Verney; James Tooley; Marianne Thoresen Journal: Brain Pathol Date: 2007-10-09 Impact factor: 6.508
Authors: Vanessa Kappel da Silva; Betânia Souza de Freitas; Arethuza da Silva Dornelles; Laura Roesler Nery; Lucio Falavigna; Rafael Dal Ponte Ferreira; Maurício Reis Bogo; Jaime Eduardo Cecílio Hallak; Antônio Waldo Zuardi; José Alexandre S Crippa; Nadja Schröder Journal: Mol Neurobiol Date: 2013-07-28 Impact factor: 5.590
Authors: Jannicke H Andresen; Birgitte Carlsen; Rønnaug Solberg; Lars Mørkrid; Ingeborg L Goverud; Else M Løberg; Ola D Saugstad Journal: J Matern Fetal Neonatal Med Date: 2009-02
Authors: B H Munkeby; C De Lange; K E Emblem; A Bjørnerud; G A B Kro; J Andresen; E H Winther-Larssen; E M Løberg; J K Hald Journal: Acta Radiol Date: 2008-11 Impact factor: 1.990
Authors: Juan F Garcia; Soledad Arribalzaga; Raquel Díez; Cristina Lopez; M Nelida Fernandez; Juan J Garcia; M Jose Diez; Jesús Seco-Calvo; Matilde Sierra; Ana M Sahagún Journal: Nutrients Date: 2022-07-04 Impact factor: 6.706
Authors: Daniel Alonso-Alconada; Francisco José Álvarez; Felipe Goñi-de-Cerio; Enrique Hilario; Antonia Álvarez Journal: Int J Mol Sci Date: 2020-02-14 Impact factor: 5.923